URGENT: Pfizer secretly halted a pivotal trial on a major new drug for sickle cell disease
In December, Pfizer quietly halted much of its work on the pivotal clinical trial of one of its most highly touted drugs, a new medicine for sickle cell disease — barely a month after telling investors it believed the drug was worth over $4 billion. The drug, osivelotor, was in a Phase 3 trial, the […]
Discuss on Nostr!
Nostr Note ID note1uuwfh7engwknk3kffa4zjenjd049ldkqzk5fqwt8cgm7aq338nusqr54qe Open on Primal.net Open on Snort.social Open on Iris.to Open on Coracle.social
New to Nostr?
Create an account now & join the conversation!
Promote it on DissentWatch!
- To advertise this post for $0.02 per visit send bitcoins to the address below
- The post will be promoted daily via social media & our "Featured News" display in multiple places
- You can add more anytime
- Ranking order in the Featured News box is based on the balance remaining
Received: 0 mBTC (0.00 USD)
Spent: 0 mBTC (0.00 USD)
Balance: 0 mBTC (0.00 USD)
The amounts above may be lagging behind. If you just sent a payment click below to get more up to date results and push the post to the "Featured News" box faster.